Rankings
▼
Calendar
BCRX FY 2009 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
FY 2009 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$75M
+31.9% YoY
Gross Profit
$70M
93.9% margin
Operating Income
-$14M
-18.4% margin
Net Income
-$13M
-18.0% margin
EPS (Diluted)
$-0.35
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$17M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$142M
Total Liabilities
$56M
Stockholders' Equity
$86M
Cash & Equivalents
$41M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$75M
$57M
+31.9%
Gross Profit
$70M
$57M
+23.8%
Operating Income
-$14M
-$27M
+49.4%
Net Income
-$13M
-$25M
+45.6%
← FY 2008
All Quarters
FY 2010 →